The 2020s: The decade of psychedelic breakthroughs?

Clinical studies are underway. How we treat them moving forward matters.

Photo credit: Joe Amon / MediaNews Group / The Denver Post via Getty Images
  • Michael Ehlers, a former executive at Biogen and Pfizer, has assumed an advisory role with Field Trip, a psychedelics research organization.
  • Ehlers has followed the science of psychedelics for more than a decade and is excited by the potential for therapeutic applications.
  • MDMA and psilocybin have been granted breakthrough therapy status by the FDA, signaling a shift in the future of mental health treatment.
Keep reading

Legalized marijuana linked to lower opioid abuse; death rates

A new study analyzed more than 1.5 billion opioid prescriptions over eight years.

Photo by Guillaume Payen/SOPA Images/LightRocket via Getty Images
  • A new study analyzed over 1.5 billion opioid prescriptions between 2011 and 2018.
  • Researchers discovered opioid prescription reductions of 11.8 percent and 4.2 percent in states that passed recreational and medical cannabis laws.
  • The U.S. government needs to reschedule cannabis because researchers believe it has therapeutic value.
Keep reading

Great moments in marijuana history are being revealed

David Bienenstock has made it his mission to keep the history of cannabis alive.

Photo courtesy of the author
  • Cannabis journalists David Bienenstock and Abdullah Saeed launched Great Moments in Weed History to share the history of marijuana.
  • They cover hilarious and amazing weed tales about Willie Nelson. Louis Armstrong, Barack Obama, and Fela Kuti.
  • In this interview with Big Think, Bienenstock says it's essential to keep the history of marijuana alive in the corporatized age.
Keep reading

Despite almost no research, the pet CBD industry will grow to $1 billion

Veterinarians are concerned. Consumers appear not to be.

Photo by Jessica Rinaldi/The Boston Globe via Getty Images
  • The pet CBD industry, valued at $8 million in 2017, is expected to grow to $1.16 billion by 2022.
  • Despite the hype, there have been few clinical studies conducted on pets.
  • While there is evidence of its potential therapeutic value, all evidence points to much higher dosages than offered on the consumer market.
Keep reading

Marijuana addiction has risen in places where it's legal

While legalization has benefits, a new study suggests it may have one big drawback.

BSIP/Universal Images Group via Getty Images
  • A new study finds that rates of marijuana use and addiction have gone up in states that have recently legalized the drug.
  • The problem was most severe for those over age of 26, with cases of addiction rising by a third.
  • The findings complicate the debate around legalization.
Keep reading